ALX Oncology Holdings Inc. (ALXO) Social Stream
Alx Oncology Holdings Inc (ALXO) Price Targets From Analysts
Use the tables below to see what analysts covering Alx Oncology Holdings Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ALXO's average price target has moved down $44.5 over the prior 42 weeks.
ALXO reports an average of 93.2% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ALXO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 90 days, ALXO's average broker recommendation rating worsened by 0.29.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Alx Oncology Holdings Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 646.69% of that group.
- In terms of how Alx Oncology Holdings Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -414.33% of that group.
- ALXO has a higher average analyst price target than 559.03% of Pharmaceutical Products stocks.
- Alx Oncology Holdings Inc's number of analysts covering the stock is greater than 417.62% of Pharmaceutical Products stocks.
Make investment decisions regarding ALXO using the data that counts. Try POWR Ratings for free.